Matthew L. Posard Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew L. Posard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew L. Posard. Matthew L. Posard is a Sr VP & General Manager in ILLUMINA INC ($ILMN) and a Sr VP & GM, Consumer Genomics in ILLUMINA INC ($ILMN) and a Director in HALOZYME THERAPEUTICS INC ($GYHT) and a Chief Commercial Officer in Trovagene, Inc. ($XNOM.OB) and a Director in Talis Biomedical Corp ($TLIS) and a Director in DermTech, Inc. ($DMTK).
Address: 5200 ILLUMINA WAY SAN DIEGO 92122 CA
Companies in which Matthew L. Posard is an Insider
Cardiff Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Matthew L. Posard: Chief Commercial Officer
Holdings: 0 shares
Latest Transaction: Jan 06 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DermTech, Inc.
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Matthew L. Posard: Director
Holdings: 86,863 shares
Latest Transaction: Jan 13 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HALOZYME THERAPEUTICS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Matthew L. Posard: Director
Holdings: 128,983 shares
Latest Transaction: May 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ILLUMINA, INC.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Matthew L. Posard: Sr VP & General Manager, Sr VP & GM, Consumer Genomics
Holdings: 30,858 shares
Current Value: $5,025,225
Latest Transaction: May 30 2013
$ILMN Market Capitalization: $23.92B
$ILMN Previous Close: $162.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Talis Biomedical Corp
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Matthew L. Posard: Director
Holdings: 62,500 shares
Latest Transaction: Feb 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Matthew L. Posard
Sentiment: All, XNOM.OB, DMTK, GYHT, ILMN, TLIS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 5,230 | 0 | 128,983 | 123.8 K to 129 K (+4.23 %) |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Posard Matthew L. | Director | Buy | P | 16.00 | 62,500 | 1,000,000 | 62,500 | 0 to 62.5 K |
| Jan 13 2021 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Buy | P | 29.50 | 33,898 | 999,991 | 86,863 | 53 K to 86.9 K (+64.00 %) |
| Jun 19 2020 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Grant | A | 0.00 | 8,000 | 0 | 52,965 | 45 K to 53 K (+17.79 %) |
| May 01 2020 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 8,829 | 0 | 123,753 | 114.9 K to 123.8 K (+7.68 %) |
| May 01 2020 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Option Exercise | M | 6.94 | 9,702 | 67,332 | 0 | |
| May 01 2020 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Buy | M | 6.94 | 9,702 | 67,332 | 44,965 | 35.3 K to 45 K (+27.51 %) |